200 Participants Needed

Sample Collection for Skin Lymphomas and Eczema

SA
JC
CL
Overseen ByCharity L Ruhl, LPN
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial focuses on collecting blood, urine, and tissue samples to aid researchers in studying cutaneous T-cell lymphoma (a type of blood cancer affecting the skin), eczema, and atopic dermatitis (both conditions causing itchy, inflamed skin). The goal is to gather samples for current and future research to enhance understanding of these conditions. Individuals diagnosed with any of these skin issues who agree to provide a blood sample or a small piece of skin may be suitable participants. As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research that could lead to improved treatments for these skin conditions.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it focuses on gathering vital biological samples, such as blood, skin, and urine, from patients with cutaneous lymphoma, eczema, and atopic dermatitis. Unlike standard treatments that directly target symptoms, this approach aims to deepen our understanding of these conditions at a molecular level. By analyzing these samples, researchers hope to uncover new insights into disease mechanisms and identify potential new targets for future therapies, ultimately paving the way for more effective and personalized treatment options.

Who Is on the Research Team?

OE

Oleg E Akilov, M.D., PhD

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

Inclusion Criteria

18 or older
able and willing to provide informed consent
diagnosed with CTCL
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Sample Collection

Collection of peripheral blood, urine, and skin samples for research purposes

Ongoing

Follow-up

Participants are monitored for safety and effectiveness after sample collection

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Blood draw
  • Skin Biopsy
  • Urine Collection

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: CTCL, atopic dermatitis, eczemaExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+